were significantly more likely to have CHD than subjects with apo B concentrations less than 1.00 g/L, the approximate 50th percentile (P <0.05 in men and P <0.001 in women).
with an increased risk of coronary heart disease (CHD) [1] [2] [3] [4] , whereas interventions that reduce LDL cholesterol concentration with diet and (or) medication result in reduced CHD risk [4] [5] [6] [7] [8] [9] [10] .
Data from the Lipid Research Clinics Coronary Primary Prevention
Trial, for example, showed that a reduction in total and LDL cholesterol of 13% and 20%, respectively, decreased fatal CHD by 24% and nonfatal myocardial infarction by 19% [4, 5] . More recently, the Scandinavian Simvastatin Survival Study Group has reported a 30% decrease in total mortality and a 42% decrease in CHD mortality in men and women with CHD and moderate hypercholesterolemia who were randomized to simvastatin treatment vs placebo [10] . As a result of such studies, the National Cholesterol Education
Program (NCEP) Adult Treatment Panel has developed guidelines for screening and treating patients on the basis of their LDL cholesterol values [11, 12] . According to these guidelines, an LDL cholesterol concentration <1.30 g/L is considered desirable, whereas a concentration 1.60 g/L is considered a high risk value for CHD. Apolipoprotein (apo) B, the protein component of LDL, mediates the uptake of LDL by liver and peripheral tissue via a specific interaction with the LDL receptor [13] . Although numerous case-control studies have shown plasma apo B concentration to be a better marker than TC or LDL cholesterol for CHD [14] [15] [16] [17] , prospective data have not confirmed this finding [18] [19] [20] [21] . [25] ; apo B was measured in an aliquot of plasma that had been stored at -80 #{176}C for 4-6 years. Information concerning menopausal status, current smoking status (yes/no), alcohol intake (drinks per week), height, and weight was collected at the time of the physical examination, as previously described [26] . Women who had not menstruated in the year preceding the examination were classified as postmeno- Apo B was measured in 40 fresh plasma samples and in aliquots that had been stored at -80 #{176}C for 1 month. We saw no significant difference in apo B concentrations between fresh and frozen samples by paired t-test analysis. The mean apo B concentration of the freshly analyzed samples was 1.15 g/L, compared with 1.18 g/L in the previously frozen specimens (P = 0.11, r = 0.93). These data suggest that short-term storage of plasma has no effect on apo B measurement.
However, we cannot rule out long-term storage as a source of bias. The profile of men and women with apo B concentrations 1.20 g/L is similar to that of individuals with high concentrations of LDL cholesterol (Table 7) . High apo B was associated 
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"#{176}Subjects with LDL-Cn1.60 g/L comparedwith subjects with LDL-C<1.30 g/L: "P <0.05, ap <0.01. #{176}P <0.001.
-C, cholesterol.
Tabie 6. CharacterIstics of subjects with iow, normai, and high concentrations of LDL choiesteroi. ""Subjects with apo B ul.20 g/L comparedwith subjects with apo B <1.00 g/L: "P <005, dp <0.001.
C, cholesterol. candy associated with CHD in men and women, whereas LDL cholesterol 1.60 g/L was less significantly associated in women and not at all associated with CHD in men. It is tempting, therefore, to conclude that apo B is a stronger risk factor for CHD than LDL cholesterol.
However, because these data were collected cross-sectionally, changes in diet and life-style may partially explain these results. The bias inherent in retrospective studies such as this make interpretation difficult. The true value of apo B measurement in assessing CHD risk in this population awaits future prospectiveanalysis of these data.
A comparison of mean or median apo B concentrations in this sample with data from previous studies is complicated because of the previous lack of standardization, the use of lyophilized calibration material (which may have introduced some bias) [30] , and differences in sampling, storage, and method-specific matrix effects [29, [31] [32] [33] . Also, the populations from which "normal" data have been reported differ with respect to age and nationality [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] . Finnish men, for example, had a higher reported mean apo B concentration than other men [34] , a finding consistent with the generally higher concentrations of TC and LDL cholesterol in that population. 
